Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system against cancer. We are leveraging our TMAb™ platform to develop highly selective therapeutics that have the potential to alter the relationship between host immune cells and cancer so that the tumor is recognized and treated as if it were an infection. Our team is comprised of lifelong learners striving for insight at the intersection of immunology, oncology and biology. We are driven to apply our scientific curiosity to the critical needs faced daily by people who are diagnosed with cancer and the physicians who treat them. We stay humble, always follow the data, and believe that our deep knowledge of cancer biology, the tumor microenvironment, and immunology will lead us to effective therapies.
Company Details
- Employees
- 23
- Founded
- 1999
- Address
- 1405 Research Blvd,
- Phone
- +1.240.243.8000
- in****@****bio.com
- Industry
- Biotechnology
- Website
- senseibio.com
- Keywords
- Immuno-oncology, Cancer vaccines, Antibodies, Companion diagnostics, Chimeric Antigen Receptor - T Cells.
- HQ
- Rockville, Maryland
Sensei Bio Questions
Sensei Bio's helpline number is +1.240.243.8000
Sensei Bio's website is senseibio.com
Sensei Bio's LinkedIn profile is https://www.linkedin.com/company/sensei-bio
Sensei Bio has
23 employees.
View email and phone details for 23
employees at Sensei Bio.
Sensei Bio's industry is
Biotechnology
Sensei Bio's top competitors are
Centessa Pharmaceuticals,
Macrogenics, Inc.,
Seismic Therapeutic,
Flagship Pioneering,
Egle Therapeutics,
Kala Bio,
Phanes Therapeutics, Inc.,
Cambrian Bio,
Cytodigm,
Salubris Biotherapeutics.
Sensei Bio's support email address is info@senseibio.com
Sensei Bio's categories are Biotechnology
Sensei Bio's founding year is 1999
